Tigermed

Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.

Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire process of clinical trials for new drug research. The founder is Ye Xiaoping. Listed on the SZSE on August 17, 2012, the company's major shareholders are Ye Xiaoping, Hong Kong Securities Clearing Co., Ltd and Cao Xiaochun. Rivals that have direct and indirect competition with Tigermed include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Generic Pharma

Founded

Dec 1, 2014

HQ location

Zhejiang, China

Legal name

Hangzhou Tigermed Consulting Co., Ltd.

Employees

1001-5000

Briefing Oct 19, 2021 10:11 AM · Healthcare

Cro stocks rose in early trading

See more